240 related articles for article (PubMed ID: 12432945)
21. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells.
Uzonyi B; Lötzer K; Jahn S; Kramer C; Hildner M; Bretschneider E; Radke D; Beer M; Vollandt R; Evans JF; Funk CD; Habenicht AJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6326-31. PubMed ID: 16606835
[TBL] [Abstract][Full Text] [Related]
22. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
Bäck M; Jonsson EW; Dahlén SE
Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
[TBL] [Abstract][Full Text] [Related]
23. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
[TBL] [Abstract][Full Text] [Related]
24. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends.
Capra V; Thompson MD; Sala A; Cole DE; Folco G; Rovati GE
Med Res Rev; 2007 Jul; 27(4):469-527. PubMed ID: 16894531
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene D
Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
[TBL] [Abstract][Full Text] [Related]
26. Exosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
Lukic A; Wahlund CJE; Gómez C; Brodin D; Samuelsson B; Wheelock CE; Gabrielsson S; Rådmark O
Cancer Lett; 2019 Mar; 444():1-8. PubMed ID: 30508568
[TBL] [Abstract][Full Text] [Related]
27. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
[TBL] [Abstract][Full Text] [Related]
28. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of cysteinyl leukotriene receptors on human platelets.
Hasegawa S; Ichiyama T; Hashimoto K; Suzuki Y; Hirano R; Fukano R; Furukawa S
Platelets; 2010; 21(4):253-9. PubMed ID: 20433311
[TBL] [Abstract][Full Text] [Related]
30. A review on leukotrienes and their receptors with reference to asthma.
Singh RK; Tandon R; Dastidar SG; Ray A
J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
[TBL] [Abstract][Full Text] [Related]
31. Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions.
Kanaoka Y; Austen KF
Adv Immunol; 2019; 142():65-84. PubMed ID: 31296303
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
33. Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum.
Huang SC
Life Sci; 2011 Apr; 88(17-18):819-24. PubMed ID: 21396378
[TBL] [Abstract][Full Text] [Related]
34. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
35. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1.
Bautz F; Denzlinger C; Kanz L; Möhle R
Blood; 2001 Jun; 97(11):3433-40. PubMed ID: 11369634
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.
Foster HR; Fuerst E; Lee TH; Cousins DJ; Woszczek G
PLoS One; 2013; 8(3):e58305. PubMed ID: 23472176
[TBL] [Abstract][Full Text] [Related]
37. Cellular signalling of cysteinyl leukotriene type 1 receptor variants CysLT₁-G300S and CysLT₁-I206S.
Yaddaden L; Véronneau S; Thompson MD; Rola-Pleszczynski M; Stankova J
Prostaglandins Leukot Essent Fatty Acids; 2016 Feb; 105():1-8. PubMed ID: 26869085
[TBL] [Abstract][Full Text] [Related]
38. CysLT
Sekioka T; Kadode M; Yonetomi Y; Kamiya A; Fujita M; Nabe T; Kawabata K
Eur J Pharmacol; 2017 Jan; 794():147-153. PubMed ID: 27887950
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma.
Capra V; Nicosia S; Ragnini D; Mezzetti M; Keppler D; Rovati GE
Mol Pharmacol; 1998 Apr; 53(4):750-8. PubMed ID: 9547367
[TBL] [Abstract][Full Text] [Related]
40. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
